Therefore, we tested whether the combination of pomalidomide with the BET family inhibitor JQ1, which inhibits MYC and IRF4 expression, could sensitize ALCL cells to IMiDs treatment. This evidence concerns the gene IRF4 and anaplastic large cell lymphoma.